ArticleAdvances in therapy2025

Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective.

Ataru Igarashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.